Research Funding Opportunities

Graham Bull Prize 2016

The Graham Bull prize was established in 1988 in honour of Sir Graham Bull, who was the first director of the Clinical Research Centre at Northwick Park. A trust for the Graham Bull Prize was set up to provide money for young research workers under the age of 45 who feel that they have made a major contribution to clinical science. The prize as designed by the trust is specifically for an application and not for nomination of individuals. The work can cover a wide range of expertise, such as molecular and cellular biology, imaging technology, psychiatry, or health sciences. The award is open to RCP members and fellows who must apply for their own work to be considered. The sum of £1,000 is offered on a competitive basis each year.

The winner of this prize will also be invited to deliver the Goulstonian Lecture, an annual lecture endowed in 1635 by Mrs Ellen Goulston in memory of her husband, Dr Theodore Goulston FRCP.


Researchers must be under the age of 45 years on 1 April 2016, and must be a member or fellow of RCP London.

How to apply

The 2016 round closes on 1 April 2016. For more information on this award please email the Funding and Awards administrator: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Proposed research areas for 2015 HTA commissioned calls - updated 8 September 2015

The HTA Programme is considering the following topic areas for future commissioned research. Please note that not all of these topics will ultimately be advertised, but if they are it is likely to be within the next 6 to 12 months. Please also note that topic areas and timings are subject to change. The individual commissioning briefs, which will be published when the call opens, will define the details of the call.

  • Selective gut decontamination in critically ill children
  • Pharmacological management of diarrhoea in patients with ulcerative colitis
  • Optimising nutrition during therapeutic hypothermia
  • To comment on any of these ideas, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

    HTA researcher-led funding opportunities - updated 8 September 2015

    The researcher-led workstream welcomes proposals on topics or research questions identified by researchers within the programme’s remit. The HTA can verify this for you if you complete and submit a remit check form. The deadlines for the next rounds are Monday 7 December 2015, Friday 8 April 2016, Wednesday 10 August 2016 and Wednesday 30 November 2016. Details can be found on the HTA website. Please note that the guidance notes have been updated since the researcher-led call launch in September 2014. Make sure you use the latest version as there have been changes to the advice on technical use of the form and costings for studies.

    Proposed research areas for 2014/15 EME commissioned calls - updated 29 September 2015

    Research in the following broad areas is likely to be commissioned during the next year, although the titles and timings may be subject to change. The individual commissioning briefs, which will be published when the calls open, will define the details of the calls.

  • Use of cell therapies: anticipated opening date November 2015
  • Delirium: anticipated opening date November 2015
  • Graft vs host disease: anticipated opening date November 2015
  • Foetal and maternal health outcomes in chronic diseases: anticipated opening date TBC
  • Clinical efficacy of novel biosensing technologies: anticipated opening date TBC

  • EME researcher-led funding opportunity 15/79 - updated 8 September 2015

    The EME Programme's researcher-led workstream is an ongoing research funding opportunity funded by the Medical Research Council. You are welcome to submit a preliminary application at any time; however, there will be three cut-off dates each year. The next deadline is 1pm on 10 November 2015. Further information is available from the EME website.

    Bowel & Cancer Research and Core Joint Development Award

    Diverticular disease is common and is the subject of 1 in 3 patient enquiries to Core, yet it is a relatively neglected area of research. This joint call from Core and Bowel & Cancer Research, under the umbrella of the Diverticular Research Campaign, is motivated by a desire to change that.

    Appropriate applications for development award funding may range from basic and translational science to research for patient benefit, including but not limited to:

    • Pathogenesis (including role of the microbiome and other mechanisms and relationship to IBS)
    • Development and validation of robust assessment tools, symptomatology and clinical impact
    • Early phase assessments of new therapeutic approaches
    • Comparison of currently available treatments or their appropriate deployment, including appropriate selection and use of surgical techniques.

    Proposals need not be narrowly focused on diverticular disease as long as they have the realistic potential to advance understanding or management of this condition. For this call there is £60,000 of funding available for two awards. The maximum funding per award is £30,000.

    Funded projects should be completed within 18 months of commencing. This call is only open to UK applicants. We will fund only the direct costs associated with the project and will not fund overhead allocation or other indirect costs, including senior or supervisory posts which are already covered by HEFCE, or other, funding. We will not fund equipment or capital costs. Applicants must have established academic positions.

    In assessing proposals equal weight will be given to the intrinsic merits of the application and to the chances that the research will lead to a further successful application for more substantial funding. It is hoped successful applications will spearhead further fundraising.

    The deadline for preliminary applications is 5pm on 12 October. Full applications will be required by 5pm on 18 January 2016.

    To download the application form and guidelines please visit:

    Bowel & Cancer Research Call for Proposals

    Bowel & Cancer Research is seeking high quality applications for consideration at its funding round in March 2016.

    Our area of interest is lower GI/ bowel research in malignant and non-malignant, diagnostic or treatment studies or device/intervention development for which future translation to tangible patient benefit can be anticipated. Areas of interest include:

    • Colorectal cancer
    • Inflammatory disease
    • IBS
    • Stoma prevention/improvement in quality of life

    Awards of up to £50,000 are available for time limited (indicatively 12 - 18 months) proof-of-principle studies based on sound hypotheses.

    Successful applicants will be expected to make a strong case for how Bowel & Cancer Research funding will be used to lever further funding to continue resulting work.

    Full guidance and preliminary application forms can be downloaded from

    This is a 2 stage process. The deadline for all preliminary applications is 5pm Friday 23rd October 2015.

    Applicants will be notified week beginning Monday 7th December 2015 if a full application is invited and final decisions will be made in March 2016.

    Crohn's and Colitis UK Research Awards 2016

    Applications are invited for grants to be awarded in 2016 by Crohn’s and Colitis UK. Research Projects may be directed towards:

    1. Medical - any aspect of Inflammatory Bowel Disease relevant to a better understanding of the causes or mechanisms of IBD or better treatment for IBD patients.
    2. Living with IBD – any aspect of the social and psychological impact of Inflammatory Bowel Disease including research into ways of helping patients and their families to live with IBD.
    3. Health Services – research with the potential to improve the services provided to the UK’s IBD community and to drive up standards of care for patients with IBD.

    Funding for any one project is normally subject to a maximum of £120,000 over a period of up to three years. Applications for funding of pilot studies are also encouraged.

    Closing date for applications is 4pm on Monday, 5th October 2015.

    An Application Form and Information for Applicants can be downloaded from or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or on 01727 734 468.

    Coeliac UK - Funding opportunity

    Coeliac UK, the leading national charity for people with coeliac disease and dermatitis herpetiformis, is launching a new round of research grant awards with up to £100k of funding available. Deadline for submission 21 September, 2015

    Researchers from all scientific disciplines are invited to submit applications that can demonstrate how their proposal will advance our understanding of the disease and improve the lives of those living with the condition.

    There is also a further £30k for research into the epidemiology of coeliac disease and dermatitis herpetiformis in the UK. Deadline for submission 5 October, 2015.

    Please visit the Coeliac UK website for further information and to download the latest application form.

    If you have any queries please contact Dr Heidi Urwin, Research Manager at Coeliac UK: This e-mail address is being protected from spambots. You need JavaScript enabled to view it or by telephone on 01494 796138

    Clinical Research Training Fellowship

    Coeliac UK has joined forces with the Medical Research Council to offer jointly funded Clinical Research Training Fellowships. Our aim is to build a funding programme that will support the creation of the next generation of researchers focusing on coeliac disease. We wish to attract clinically active professionals within the UK and encourage them to embark on an early career in coeliac disease.

    For further information and to submit an application, please visit the Medical Research Council. The Medical Research Council provides the most up to date list of deadlines, including interview and take up dates.

    The Crohn's in Childhood Research Association offers the following Research Opportunities

    Research Fellowship in Paediatric Gastroenterology: Applications are invited from interested Paediatric Gastroenterology Centres in the UK for a 2 or 3 year clinical/scientific training post for paediatricians in training seeking to specialize in paediatric gastroenterology with an interest in IBD. Closing date for receipt of applications - Friday 16th October 2015.

    PhD studentship: CICRA invites applications from research groups with a proven track record of high quality output in gut immunology and inflammation or IBD genetics. Fees and stipends in line with MRC rates. Closing date for receipt of applications - Friday 16th October 2015.

    Project grant: CICRA invites high quality research applications relevant to Crohn's disease or Ulcerative Colitis in childhood for a 1 or 2 year Project Grant of up to £100,000 p.a. Closing date for receipt of applications: Friday 16th October 2015.

    New for 2015

    2 year post doctoral Fellowship: Applications are invited from non-clinician scientists with a PhD wishing to undertake scientific research that must be relevant/involve children with Inflammatory Bowel Disease (IBD) This initiative is designed to attract basic scientists (e.g. immunologists, microbiologists, geneticists etc) in the field of IBD relevant to children. Closing date for receipt of applications Friday 16th October 2015.

    In addition to the four main funding streams CICRA also gives:

    Bursary grants of up to £400 (up to a total amount of £5,000pa) to enable UK based young doctors still in training/nurses/final year medical students and similar persons with an interest in the area of Crohn's and colitis (IBD) to support attendance at national, international scientific/educational congresses and if considered appropriate IBD related training courses. Also a £1000 annual bursary for travel/registration at national and international meetings for doctors in training to become paediatric gastroenterologists.

    Application forms and further information can be obtained from the CICRA website:

    World Cancer Research Fund International Regular Grant Programme 2015/2016

    On Monday 13 July 2015, the 2015/2016 cycle will open for applications on the effects of diet, nutrition (including body composition) and physical activity on cancer. Applicants can be based in any country outside the Americas. More information on the eligibility and the scientific scope of the grant call is available. Please ensure you read the ‘Guidelines for research grant applicants & award recipients’ carefully before applying. The deadline for applications is 9 October 2015.

    EME funding opportunity 15/75 - Mechanisms of action of health interventions

    Proposals are sought for translational research into the underlying mechanisms of action of clinical and public health interventions. Studies must utilise patients or samples from current or completed NIHR-funded or NIHR-managed studies in any setting. Proposals will be accepted across a wide range of interventions, including behavioural, pharmaceutical, psychological, surgical and public health interventions. The research should be relevant to the intervention and outcomes proposed by the original study and add significantly to the scientific understanding of the mechanisms of action of the intervention.

    The proposed research may involve the analysis or reanalysis of previously stored specimens or data, or the collection of new specimens or new data for additional analysis, provided it is obtained from study participants. Discovery of new biomarkers is not within the remit of the EME Programme.

    Applicants will need to make a strong case for how a better understanding of the mechanisms of action will potentially contribute to the future use or development of the technology, future wealth creation and for the ultimate benefit of individual patients’ or the wider NHS.

    Further details of the commissioning brief are available to download, along with the guidance notes. The deadline for applications is 1pm on 10 November 2015. There is a webinar on 31 July 2015 from 11:00 to 11:45 to support the application process; click here to register.

    EME funding opportunity 15/74 - Novel diagnostics and treatments for irritable bowel syndrome

    A call has been made for proposals focussed on the diagnosis or treatment of irritable bowel syndrome. Applicants are encouraged to include a hypothesis-driven mechanistic element embedded within the main efficacy study to help better understand the mechanisms of the disease process or the proposed intervention are particularly encouraged. In the light of recent calls, applications for probiotics and faecal transplant therapies will not be favoured. Applications may investigate novel or repurposed interventions and technologies.

    Further details of the commissioning brief are available to download, along with the guidance notes. The deadline for applications is 1pm on 10 November 2015..There is a webinar on 01 September 2015 from 12:00 to 12:45 to support the application process; click here to register.

    EME funding opportunity 15/73 - Markers of early treatment response in non-cancerous conditions

    A call has been made for translational research proposals into the early use of markers to assess and predict the further response to treatment of patients with non-cancerous conditions. This will contribute to the development of a personalised medicine approach to healthcare and help inform patient management decisions by enabling stratification of patients following initiation of treatment. Applications must concentrate on determining the clinical efficacy of the marker early in treatment. Applications to this call could focus on either the test or the use of a test to change the care pathway of patients.

    Further details of the commissioning brief are available to download, along with the the guidance notes. The deadline for applications is 1pm on 10 November 2015. There is a webinar on 27 July 2015 from 13:15 to 14:00 to support the application process; click here to register.

    MRC Biochemical Catalyst: Developmental Pathway Funding Scheme - reminder

    The DPFS scheme is a key part of the MRC's Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies. DPFS is an ongoing scheme, with outline deadlines every 4 months. The next deadline for outline proposals is 4pm on 2 December 2015. Please note that full submissions to DPFS are by invitation only; submission to the full call is contingent upon prior submission and shortlisting of an outline proposal. Further details are available from the MRC website.

    Pump prime funding for initial feasibility studies

    NIHR Enteric HTC aims to identify and address unmet clinical need in the diagnosis and management of disorders of the gastrointestinal tract and bowel function. The HTC seeks new ideas for medical device innovations and offers the opportunity to apply to NIHR Enteric HTC for pump prime funding for initial feasibility studies on potential new medical technologies within the field of digestive diseases and GI surgery.

    MRC Public Health Intervention Development Scheme (PHIND)

    The Public Health Intervention Development scheme (PHIND) is a new MRC funding scheme designed specifically to provide support for early phase development of public health interventions. This rapid response funding scheme is aimed at improving the initial evidence on which the development and evaluation of public health interventions are based. Studies should address an important UK or global public health issue and offer an innovative approach to intervention development or applying an existing intervention in a new setting.

    The scheme's remit ranges from primary research developing and designing the intervention to feasibility studies, encompassing:

    • developing theory
    • modelling process and outcomes
    • assessing feasibility

    Systematic reviews, meta analyses and pilot studies are outside the remit of the PHIND scheme. Applicants can apply for up to £150K for a maximum of 18 months and the scheme will operate three times a year. For further information, please see the MRC website.